22/12/2014 04:09:25 Free Membership Login

   

Anthera Pharmaceuticals, Inc.

Visual Financials
Company Name: Anthera Pharmaceuticals, Inc.
Ticker Symbol: ANTH
WWW Address: http://www.anthera.com
CEO: Paul Truex
No. of Employees: 23
Common Issue Type: CS
Business Description:Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases.

 
Industry Information: DRUGS - Drug Manufacturers - Major [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 1.6 Unchanged 0.0 1.54 1.6  1.72 1.58 -
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 36.7 22.9 0.00 -1.69 0.00 0.0 0.0 3.79 - 1.53
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close1.59$
PE Ratio - LTM0.0
Market Capitalisation36.7mil
Latest Shares Outstanding22.9mil
Earnings pS (EPS)-1.69$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee$
Effective Tax Rate%
Float19.3mil
Float as % of Shares Outstanding1.0%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.00%
Research & Devlopment (R&D) as % of Revenue0.00%
Gross Profit Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Assets Turnover0.0%
Return on Assets (ROA)-96.6%
Return on Equity (ROE)-549.5%
Return on Capital Invested (ROCI)-113.8%
Current Ratio3.5
Leverage Ratio (Assets/Equity)2.5
Interest Cover-10.9
Total Debt/Equity (Gearing Ratio)1.21
LT Debt/Total Capital51.0%
Working Capital pS0.82$
Cash pS0.00$
Book-Value pS0.19$
Tangible Book-Value pS0.64$
Cash Flow pS-1.20$
Free Cash Flow pS-1.20$
KEY FIGURES (LTM): Price info
Price/Book Ratio8.15
Price/Tangible Book Ratio0.00
Price/Cash Flow-1.3
Price/Free Cash Flow-1.3
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---2.493.47-49-18
4 Weeks1.721.581.582.493.4727
13 Weeks1.591.591648811.583.7927
26 Weeks1648812.492.491.843.792-8
52 Weeks1.581.581.832.491.532-8
YTD1.531.53-2.491.53-2-39
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
1.531.531.591.593.550.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue341764621343382134338
Income341764634176469529387
Dividend95293871977530119775301
Capital Spending38775261NA38775261
R&D2704577NA2704577
Normalized Inc.9529387NA9529387
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %-57-62-62
Earnings %-53-53-62
EPS %938686
EPS $-625151
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio0.00
Current Ratio37417000
Quick Ratio (Acid Test)11113000
Liquidity Ratio (Cash)0.00
Receivables Turnover
Average Collection Period
Working Capital/Equity
Working Capital pS
Cash-Flow pS
Free Cash-Flow pS14758000
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.00
Financial Leverage Ratio (Assets/Equity)3519000
Debt Ratio22659000
Total Debt/Equity (Gearing Ratio)No
LT Debt/Equity
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities22659000
Interest Cover-816000
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.00
Current P/E Ratio - LTM19,853,675.00
Enterprise Value (EV)/EBITDA0.00
Enterprise Value (EV)/Free Cash Flow18.75
Dividend Yield1277198
Price/Tangible Book Ratio - LTM110
Price/Book Ratio - LTM153750
Price/Cash Flow Ratio3.5
Price/Free Cash Flow Ratio - LTM110
Price/Sales Ratio-14.00
P/E Ratio (1 month ago) - LTM19853675
P/E Ratio (26 weeks ago) - LTM29471246
P/E Ratio (52 weeks ago) - LTM29471246
5-Y High P/E Ratio38898961
5-Y Low P/E Ratio37773792
5-Y Average P/E Ratio196061
Current P/E Ratio as % of 5-Y Average P/E196061
P/E as % of Industry Group170,882.0
P/E as % of Sector Segment170,882.0
Current 12 Month Normalized P/E Ratio - LTM194,030.0
PER SHARE FIGURES
LT Debt pS
Current Liabilities pS
Tangible Book Value pS - LTM3.5
Book Value pS - LTM153750
Capital Invested pS0.00
Cash pS - LTM2054
Cash Flow pS - LTM2.26
Free Cash Flow pS - LTM2.26
Earnings pS (EPS)-43
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin0.00
Free Cash Flow Margin 5YEAR AVG0.00
Net Profit Margin-816000
Net Profit Margin - 5YEAR AVRG.2014-11-10
Equity Productivity0.00
Return on Equity (ROE)14758000
Return on Equity (ROE) - 5YEAR AVRG.36244493
Capital Invested Productivity0.00
Return on Capital Invested (ROCI)
Return on Capital Invested (ROCI) - 5YEAR AVRG.-100
Assets Productivity3,519,000.00
Return on Assets (ROA)
Return on Assets (ROA) - 5YEAR AVRG.36244493
Gross Profit Margin170882
Gross Profit Margin - 5YEAR AVRG.-100
EBITDA Margin - LTM146605
EBIT Margin - LTM170882
Pre-Tax Profit Margin812000
Pre-Tax Profit Margin - 5YEAR AVRG.22939553
Effective Tax Rate100.0
Effective Tax Rate - 5YEAR AVRG.100.0
EFFICIENCY RATIOS
Cash Conversion Cycle7,561,213
Revenue per Employee
Net Income per Employee
Average Collection Period
Receivables Turnover
Day's Inventory Turnover Ratio7561000
Inventory Turnover
Inventory/Sales
Accounts Payble/Sales0.00
Assets/Revenue0.00
Net Working Capital Turnover0.00
Fixed Assets Turnover0.00
Total Assets Turnover3519000
Revenue per $ Cash1265000
Revenue per $ Plant1265000
Revenue per $ Common Equity
Revenue per $ Capital Invested
Selling, General & Adm/tive (SG&A) as % of Revenue-22436000
SG&A Expense as % of Revenue - 5YEAR AVRG.22939553
Research & Devlopment (R&D) as % of Revenue-22436000
R&D Expense as % of Revenue - 5YEAR AVRG.-22436000

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq anth141222 04:09